Biofilm infections, their resilience to therapy and innovative treatment strategies
By U. Römling, C. Balsalobre. Journal of Internal Medicine, 2012
841 citations recorded by the source corpus.
Subfields: Immunology, Microbiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/89a3a4c2747bbd456a0b7721d6dbb8004b29fb48
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Microbiology
In Molecular Biology
- Minh Thu Tran Thi
- David Wibowo
- Robert E. W. Hancock
- Bernd H. A. Rehm
- César de la Fuente-Núñez
- S. Ghods
- R. Vasudevan
- M. F. Moradali
Citations in the corpus
- Pseudomonas aeruginosa Biofilms (2020, background): “As a result, highly structured biofilms can be formed which is often identified in patients with chronic infections, such as chronic lung infection, chronic wound infection and chronic rhinosinusitis [7].”
- Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence (2017, background): “Other P. aeruginosa biofilm associated infections include chronic wound infection, chronic otitis media, chronic rhinosinusitis, catheter-associated urinary tract infection, and contact lens-related keratitis (Römling and Balsalobre, 2012).”
- Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. (2013, background): “In the clinic, biofilm infections are usually treated with combinations of antibiotics [11,12,13 ,14].”
- Biofilms: Microbial Cities of Scientific Significance (2014, background): “Researchers and scientific investigators have carried out several demonstrative studies to understand the molecular mechanisms of bacterial biofilms which is essential for the development of a suitable biofilm model which can be employed to perform in vivo studies to reveal innovative means of thera”